Aortic valve replacement: validation of the Toronto Aortic Stenosis Quality of Life Questionnaire

Aims There is no quality of life tool specifically developed for patients with severe aortic stenosis (AS) to assess how this chronic condition and its treatment affect patients. The Toronto Aortic Stenosis Quality of Life Questionnaire (TASQ) has been developed to overcome this gap. The results of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ESC Heart Failure 2021-02, Vol.8 (1), p.270-279
Hauptverfasser: Frank, Derk, Kennon, Simon, Bonaros, Nikolaos, Stastny, Lukas, Romano, Mauro, Lefèvre, Thierry, Di Mario, Carlo, Stefàno, Pierluigi, Ribichini, Flavio, Himbert, Dominique, Urena‐Alcazar, Marina, Salgado‐Fernandez, Jorge, Castillo, Jose Joaquin Cuenca, Garcia del Blanco, Bruno, Deutsch, Cornelia, Sykorova, Lenka, Kurucova, Jana, Thoenes, Martin, Lüske, Claudia M., Bramlage, Peter, Styra, Rima
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aims There is no quality of life tool specifically developed for patients with severe aortic stenosis (AS) to assess how this chronic condition and its treatment affect patients. The Toronto Aortic Stenosis Quality of Life Questionnaire (TASQ) has been developed to overcome this gap. The results of the validation of the TASQ in patients undergoing treatment for severe AS are presented. Methods and results Prospective study at 10 centres in Europe and Canada, which enrolled 274 patients with severe symptomatic AS undergoing surgical or transcatheter aortic valve replacement. Mean TASQ score at baseline was 71.2 points and increased to 88.9 three months after aortic valve implantation (P 
ISSN:2055-5822
2055-5822
DOI:10.1002/ehf2.12961